Navigation Links
NJ-Based, Minority Woman-Owned Firm Tapped to Promote Alzheimer’s Disease Drug Trial
Date:1/10/2017

Impact Consulting Enterprises, a strategic communication, marketing and public relations firm based in East Orange, N.J., has signed a deal with Suven, Inc., a Monmouth Junction, N.J.-based pharmaceutical company, to promote Suven’s launch of a clinical drug trial for SUVN-502, a promising new Alzheimer’s disease medication.

The drug trial recently began at New Jersey-based testing sites in Mercer, Monmouth and Ocean counties. Other testing sites across the country can be found on the company’s website at http://www.suvn502study.com.

“We are pleased and honored to represent Suven and its team of investigators working on this important drug trial,” said Cheryl McCants, president and CEO of Impact. “SUVN-502 could bring hope to millions of Americans living with Alzheimer’s disease. We want everyone who qualifies for the trial to participate.”

Suven is seeking people ages 50 to 85 who have been diagnosed with moderate Alzheimer’s and who are taking two standard medications for the disease - donepezil and memantine/Namenda XR®. The clinical testing is designed to examine the efficacy of SUVN-502 on mental abilities impaired by Alzheimer’s.

Scientific research has shown that people with Alzheimer’s have decreased levels of acetylcholine, a neurotransmitter in the brain essential for processing memory and learning. “SUVN-502 directly stimulates the production of this vital chemical [acetylcholine],” said Dr. Jeffrey Apter, medical director at Princeton Medical Institute and a member of the New Jersey Alzheimer’s Association Scientific Advisory Committee.

Dr. Jeffrey Apter, one of the investigators in Suven’s clinical trial, said research on new medications is essential since no new drug has been approved for Alzheimer’s in more than 20 years. “SUVN-502 offers a new mechanism to enhance drugs like Aricept when all the acetylcholine in the brain is no longer present for Aricept to work,” Apter said.

More than 5 million Americans, including 170,000 in New Jersey, are living with Alzheimer’s disease, a progressive brain disorder that slowly destroys memory and thinking skills, according to the Alzheimer’s Association. Alzheimer’s has no current cure, but treatment for symptoms are available and research continues.

Interested individuals, caregivers or physicians can visit http://www.suvn502study.com to pre-qualify themselves, loved ones or patients for participation. People may also call Impact’s offices at 973-337-2028 or the Princeton Medical Institute at 609-921-6050 for additional information.

Impact Consulting Enterprises is a minority- and woman-owned strategic communication, marketing and public relations firm. McCants was recently named as one of the country’s Top Women in PR by PRNews, as well as one of the Top 25 Leading Woman Entrepreneurs in New Jersey by Leading Women Entrepreneurs of Clinton, N.J.

###

Read the full story at http://www.prweb.com/releases/2017/01/prweb13970451.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related medicine news :

1. CEO and President at T.E.N. & CEO and Chairman at ISE® Talent, Marci McCarthy, to Moderate Key Panels at Inaugural Conference of Minority Cybersecurity Professionals
2. Concept Software & Services, Inc. receives new status as a Minority Business Graduate of Tuck’s Executive Education Minority Business Program
3. AAMC Career Fair Focuses on Minority Doctors; Panel Explores Decline of Black Males in Medicine
4. PRC: A Certified Minority Business Enterprise
5. Georgia State, Morehouse Partner To Tackle Diabetes, Heart Disease In Atlanta’s Minority Communities
6. Access Therapies, Inc a Nationally Minority Owned Certified Company Announces Filing an Application for Submittal to GSA in order to Win Five-Year Government Contract.
7. Sandbridge Capital Acquires a Minority Stake in BackJoy
8. Tonsillectomy Complications May Be More Likely in Poor, Minority Kids
9. Minority Neighborhoods Face Greater Exposure to Air Pollution
10. Bowers to receive GSAs 2014 Minority Mentorship Award
11. AGA showcases its commitment to improving the pipeline of minority researchers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2017)... ... ... Axiad IDS , a leading provider of trusted identities for enterprise, ... a “Top 25 Cybersecurity Companies 2017.” Axiad IDS received this honor in ... address potential cybersecurity threats before they happen. The annual list of top ...
(Date:5/23/2017)... (PRWEB) , ... May 23, 2017 , ... ... the pharmaceutical and medical device sectors, today announced the winners of its 3rd ... Entrepreneurs) represent the most influential people in the healthcare industry today. , Out ...
(Date:5/23/2017)... ... May 23, 2017 , ... New England Journal Of Medicine Confirms Viability of ... Response”, -The Rory Staunton Foundation Calls on Health & Human Services, Tom Price to ... ( http://www.rorystauntonfoundation.org ) today reported on a new study released on May 21, 2017 ...
(Date:5/23/2017)... ... May 23, 2017 , ... The National ... is pleased to announce the organization’s Certified Strength Coach credential has earned accreditation ... Coach (CSC) program validates the competency of qualified candidates for jobs in the ...
(Date:5/23/2017)... ... May 23, 2017 , ... ... Reconstructive Surgeon Dr. Kevin Sadati, is pleased to announce a new treatment option ... and elastin in their face, neck, and body through a virtually pain-free, non-surgical ...
Breaking Medicine News(10 mins):
(Date:5/4/2017)... Fix Inc. (" Fortuna "), a private, clinical-stage biotech ... need for embryonic and fetal stem cells by using direct ... Fortuna announced today the launch of its Scientific ... PhD; Father Kevin FitzGerald , S.J., PhD; Col. (R) ... Giordano , PhD. "We are excited and honored ...
(Date:5/4/2017)... , May 4, 2017  DarioHealth Corp. (NASDAQ: ... health and big data solutions, today announced that it ... Company, and STI Technologies Limited to lower diabetes healthcare ... Through STI,s innoviCares card, which is available throughout all ... DarioHealth customers will be eligible for additional savings when ...
(Date:5/3/2017)... ROCKVILLE, Md. , May 3, 2017 /PRNewswire/ ... revenue growth of nine percent next year and ... solid organ and hematopoietic stem cell (HSCT) or ... and donor. Molecular testing technologies are well-suited for this ... healthcare-only market research publisher Kalorama Information. The various ...
Breaking Medicine Technology: